Search research articles
Contact Us
Filters
Showing results (251-260 of 481) with videos related to
Page
of 49
Sort By:
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
The Journal of Urology
|
April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer
William D Figg, Sukyung Woo, Wenhui Zhu, et al.
Journal of Clinical Immunology
|
August 8, 2016
Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience
Paul L Feingold, Humair S Quadri, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer
Nicole J McCarthy, Xiaowei Yang, Ilona R Linnoila, et al.
Plos One
|
March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis
Courtney A Granville, Regan M Memmott, Andria Balogh, et al.
Bone Marrow Transplantation
|
July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
David Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Nature Communications
|
October 28, 2025
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling
Anish Thomas, Nobuyuki Takahashi, Lenka Oplustil O'Connor, et al.
Cancer Immunology Research
|
April 30, 2014
Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer
James L Gulley, Ravi A Madan, Kwong Y Tsang, et al.
Gynecologic Oncology
|
August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment
Jung-Min Lee, Christina M Annunziata, John L Hays, et al.
Journal of Translational Medicine
|
January 30, 2010
A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma
Osama E Rahma, Ed Ashtar, Ramy Ibrahim, et al.
Page
of 49
Search research articles
Search
Showing results (251-260 of 481) with videos related to
Sort By:
Page
of 49
Leukemia & Lymphoma
|
August 10, 2017
Host-related immunodeficiency in the development of multiple myeloma
Talib Dosani, Sham Mailankody, Neha Korde, et al.
The Journal of Urology
|
April 20, 2010
A phase I clinical study of high dose ketoconazole plus weekly docetaxel for metastatic castration resistant prostate cancer
William D Figg, Sukyung Woo, Wenhui Zhu, et al.
Journal of Clinical Immunology
|
August 8, 2016
Thoracic Surgery in Chronic Granulomatous Disease: a 25-Year Single-Institution Experience
Paul L Feingold, Humair S Quadri, Seth M Steinberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
Microvessel density, expression of estrogen receptor alpha, MIB-1, p53, and c-erbB-2 in inflammatory breast cancer
Nicole J McCarthy, Xiaowei Yang, Ilona R Linnoila, et al.
Plos One
|
March 31, 2009
A central role for Foxp3+ regulatory T cells in K-Ras-driven lung tumorigenesis
Courtney A Granville, Regan M Memmott, Andria Balogh, et al.
Bone Marrow Transplantation
|
July 20, 2023
Predictors and significance of kidney dysfunction in patients with chronic graft-versus-host disease
David Beshensky, Filip Pirsl, Noa G Holtzman, et al.
Nature Communications
|
October 28, 2025
Tumor-targeted top1 inhibitor delivery with optimized parp inhibition in advanced solid tumors: a phase i trial of gapped scheduling
Anish Thomas, Nobuyuki Takahashi, Lenka Oplustil O'Connor, et al.
Cancer Immunology Research
|
April 30, 2014
Immune impact induced by PROSTVAC (PSA-TRICOM), a therapeutic vaccine for prostate cancer
James L Gulley, Ravi A Madan, Kwong Y Tsang, et al.
Gynecologic Oncology
|
August 5, 2020
Phase II trial of bevacizumab and sorafenib in recurrent ovarian cancer patients with or without prior-bevacizumab treatment
Jung-Min Lee, Christina M Annunziata, John L Hays, et al.
Journal of Translational Medicine
|
January 30, 2010
A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic renal cell carcinoma
Osama E Rahma, Ed Ashtar, Ramy Ibrahim, et al.
Page
of 49